Get started
Author

Firas Fneish

Observed names: F Fneish, F. Fneish, Firas Fneish, -, Fneish, F., Fneish, Firas
ORCID: 0000-0001-8279-8463
Observed ORCID: 0000-0001-8279-8463
OpenAlex ID: A5069026255
Data harmonization for collaborative research among MS registries: A case study in employment
2020 · A Salter, A Stahmann, et al. · Multiple Sclerosis Journal · 23
SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational study
2022 · Niklas Frahm, Firas Fneish, et al. · The Lancet Regional Health - Europe · 22
Management of MS Patients Treated With Daclizumab – a Case Series of 267 Patients
2020 · Paulus S. Rommer, Klaus Berger, et al. · Frontiers in Neurology · 19
PDF
Piper crocatum Ruiz & Pav. ameliorates wound healing through p53, E-cadherin and SOD1 pathways on wounded hyperglycemia fibroblasts
2021 · Andina Setyawati, Mae Sri Hartati Wahyuningsih, et al. · Saudi Journal of Biological Sciences · 17
PDF
Aggressive multiple sclerosis: a matter of measurement and timing
2020 · David Ellenberger, Peter Flachenecker, et al. · Brain · 16
PDF
Therapy Switches in Fingolimod-Treated Patients with Multiple Sclerosis: Long-Term Experience from the German MS Registry
2022 · Niklas Frahm, Firas Fneish, et al. · Neurology and Therapy · 15
PDF
Treatment switches of disease-modifying therapies in people with multiple sclerosis: long-term experience from the German MS Registry
2024 · Niklas Frahm, David Ellenberger, et al. · Therapeutic Advances in Neurological Disorders · 12
Characteristics of secondary progressive multiple sclerosis: Disease activity and provision of care in Germany – A registry-based/multicentric cohort study
2021 · Niklas Frahm, David Ellenberger, et al. · Multiple Sclerosis and Related Disorders · 12
PDF
Disease-modifying therapy initiation patterns in multiple sclerosis in three large MS populations
2024 · Alexander Stahmann, Elaine Craig, et al. · Therapeutic Advances in Neurological Disorders · 9
Frequency and Predictors of Relapses following SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis: Interim Results from a Longitudinal Observational Study
2023 · Niklas Frahm, Firas Fneish, et al. · Journal of Clinical Medicine · 8
PDF
Improving Risk Assessment in Clinical Trials: Toward a Systematic Risk-Based Monitoring Approach
2021 · Firas Fneish, Frank Schaarschmidt, et al. · Current Therapeutic Research · 6
PDF
Patient Benefit of Clinical Research in Diversely Advanced African Developing Countries
2021 · Vanessa Strüver, Sheraz Ali, et al. · Current Therapeutic Research · 5
PDF
Occurrence and Risk Factors of Relapse Activity after Vaccination against COVID-19 in People with Multiple Sclerosis: 1-Year Follow-Up Results from a Nationwide Longitudinal Observational Study
2023 · Firas Fneish, Niklas Frahm, et al. · Vaccines · 4
PDF
Rolle von Komorbiditäten bei Multipler Sklerose nicht unterschätzen
2022 · Niklas Frahm, Firas Fneish, et al. · NeuroTransmitter · 4
Prediction Intervals for Overdispersed Poisson Data and Their Application in Medical and Pre‐Clinical Quality Control
2024 · Max Menssen, Martina Dammann, et al. · Pharmaceutical Statistics · 3
PDF
Application of Statistical Methods for Central Statistical Monitoring and Implementations on the German Multiple Sclerosis Registry
2023 · Firas Fneish, David Ellenberger, et al. · Therapeutic Innovation & Regulatory Science · 3
PDF
Comparison of Non-Commercial Risk Based Monitoring Tools by Their Application on Clinical Trial Protocols
2020 · Firas Fneish · American Journal of Biomedical Science & Research · 3
PDF
The Temporal Development of Clinical Research in Emerging Countries
2021 · Vanessa Strüver, Firas Fneish, et al. · American Journal of Clinical and Experimental Medicine · 2
PDF
Birch pollen-induced signatures in dendritic cells are maintained upon additional cytomegalovirus exposure
2024 · Zeinab Fneish, Jennifer Becker, et al. · Gene · 1
PDF
Review of: "Integrity of Clinical RCTs: Safeguarding Trust, Evidence, and Patient Welfare"
2026 · Firas Fneish
PDF
Real-world data on the prevalence and therapy of symptomatic bladder dysfunction in people with multiple sclerosis
2026 · Mathia Kirstein, Niklas Frahm, et al. · Therapeutic Advances in Neurological Disorders
Impact of Weight-bearing and Sex-stratified Differences in Risk Factors of Bone Loss on Bone Mineral Density in Hiv Conditions
2026 · Adedayo Tunde Ajidahun, Akachukwu Omumuagwula Nwosu, et al. · World Physiotherapy Congress Archive
Higher disease reactivation risk in women after fingolimod withdrawal
2026 · Marine Massy, Stefanie Marti, et al. · Acta Neuropathologica Communications
Higher disease reactivation risk in women after fingolimod withdrawal.
2026 · Massy, Marine, Marti, Stefanie, et al. · Open Access CRIS of the University of Bern
Additional file 1 of Higher disease reactivation risk in women after fingolimod withdrawal
2026 · Marine Massy, Stefanie Marti, et al. · Figshare
Works count: 64
Citation count: 185
H-index: 9
I10-index: 8
Year
Topic
Type